Detalles de la búsqueda
1.
HBV reactivation in HBsAg-/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs.
Liver Int
; 44(2): 497-507, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010984
2.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208843
3.
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
Gut
; 71(1): 176-184, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33408122
4.
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.
Clin Infect Dis
; 75(3): 453-459, 2022 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864948
5.
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial.
Clin Gastroenterol Hepatol
; 20(12): 2800-2808, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864158
6.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333150
7.
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV.
BMC Infect Dis
; 22(1): 351, 2022 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397497
8.
Identification and management of contraindicated drug-drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy.
J Formos Med Assoc
; 121(1 Pt 1): 58-65, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33518448
9.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
J Formos Med Assoc
; 121(8): 1567-1578, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123849
10.
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Liver Int
; 41(6): 1265-1277, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655714
11.
Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy.
BMC Gastroenterol
; 21(1): 30, 2021 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33478399
12.
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
J Gastroenterol Hepatol
; 36(10): 2884-2892, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963615
13.
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.
J Gastroenterol Hepatol
; 36(8): 2247-2254, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624849
14.
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
Dig Dis Sci
; 66(11): 4026-4034, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387124
15.
The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma.
J Formos Med Assoc
; 120(3): 965-973, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33129621
16.
Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.
J Formos Med Assoc
; 120(5): 1249-1258, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33288401
17.
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Am J Gastroenterol
; 115(8): 1226-1235, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221162
18.
Characteristics of regulatory T-cell function in patients with chronic hepatitis B and C coinfection.
J Viral Hepat
; 27(8): 800-809, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243022
19.
Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients.
Dig Dis Sci
; 65(5): 1385-1395, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31559553
20.
Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy.
J Formos Med Assoc
; 119(10): 1483-1489, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653388